quinoxaline

2-(2',3',4'-Trihydroxybutyl)quinoxaline is a food metabolite.

(S,S)-2,3-Bis(t-butylmethylphosphino)quinoxaline is a useful organic compound for research related to life sciences and the catalog number is T64832.

(6bR,10aS)-Ethyl 3-methyl-2-oxo-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(9H)-carboxylate is a useful organic compound for research related to life sciences. The catalog number is T67022 and the CAS number is 313369-25-4.

TANDEM (quinoxaline) is a synthetic analog of antibiotics quinoxaline.

2,3-Bis((R)-tert-butyl(methyl)phosphino)quinoxaline is a useful organic compound for research related to life sciences. The catalog number is T66640 and the CAS number is 866081-62-1.

(6bR,10aS)-Ethyl 3-methyl-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(9H)-carboxylate is a useful organic compound for research related to life sciences. The catalog number is T67021 and the CAS number is 313369-26-5.

(6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline is a useful organic compound for research related to life sciences. The catalog number is T67023 and the CAS number is 313368-85-3.

Sulfonyl quinoxaline 1 is an inhibitor of RhoG-hepcidin uptake.

Chloroquinoxaline sulfonamide (Chloroquinoxaline) is a topoisomerase II alpha beta toxin with antitumor activity and immunosuppressive properties that inhibits the proliferation of B16 melanoma cells in mice, and can be used to study metastatic colorectal cancer. It can be used to study metastatic colorectal cancer.

Sulfaquinoxaline (Sulfabenzpyrazine) is an antiprotozoal agent.

Sulfaquinoxaline sodium salt (SQ-Na) is a veterinary broad-spectrum antimicrobial agent with antigram-negative and gram-positive activity.Sulfaquinoxaline can be used to prevent coccidiosis and bacterial infections.

Benzoquinoquinoxaline (BQQ) is a heterocyclic compound with aminoalkyl side chains containing benzo and quinoline ring structures.BQQ is triple-helix specific stabilizing compounds by preferentially binding to DNA triple junctions and inserting between the bases.Complexes of BQQ with 1,10-phenanthroline are able to bind specifically to and cleave double-stranded DNA at the cleave double-stranded DNA at sites that form triple structures.

6-Quinoxalinecarboxylic acid, 2,3-bis(bromomethyl)-, derived from 2,3-Bis(bromomethyl)quinoxaline, displays antibacterial properties.

2-Methyl-3-phenylquinoxaline (compound 38) serves as an effective inhibitor of the Platelet-Derived Growth Factor Receptor Tyrosine Kinase (PDGF-RTK), exhibiting significant inhibitory activity against the full-length PDGFR kinase in intact cells (IC50 greater than 100 μM).

Sulfaquinoxaline-d4 is a deuterated compound of Sulfaquinoxaline.

2-Quinoxalinecarboxylic acid-d4 is a deuterated compound of 2-Quinoxalinecarboxylic acid. 2-Quinoxalinecarboxylic acid has a CAS number of 879-65-2.

3-Methyl-2-quinoxalinecarboxylic Acid-d4 is a deuterated compound of 3-Methyl-2-quinoxalinecarboxylic Acid. 3-Methyl-2-quinoxalinecarboxylic Acid has a CAS number of 74003-63-7. 3-Methyl-2-quinoxalinecarboxylic acid has a wide range of applications in life science related research.

DPBQ (ZINC1620467) is a p53 activator. DPBQ could activate p53 and trigger apoptosis in a polyploid-specific manner, without inhibition of topoisomerase or bind DNA.

Erdafitinib (JNJ-42756493), a quinoxaline derivative, targets FGFR1 2 3 4.

4'-Bromomethyl-2-cyanobiphenyl is a halogenated benzonitrile used in protein-binding studies of quinoxaline angiotensin II receptor antagonists.

Olaquindox is an orally active antibiotic that is a quinoxaline derivative. It stimulates growth and reduces intestinal mucosal immunity in piglets.

Brimonidine Tartrate (AGN190342 tartrate) is a quinoxaline derivative and adrenergic α-2 receptor agonist (EC50: 0.45 nM) that is used to manage intraocular pressure associated with open-angle glaucoma or ocular hypertension.

DNQX disodium salt is a water-soluble form of selective antagonist of non-NMDA receptor

NPS2390 is a first generation quinoxaline derivative that acts as a noncompetitive antagonist of mGluR1 and mGluR5 (IC50 of 5.2 and 82 nM, respectively)